EPCAM and cancer: Typically, immunomagnetic cell isolation devices use epithelial markers, mostly EpCAM, for CTC detection neglecting the fact that cancer cells undergo morphological changes during epithelial-to-mesenchymal transition (EMT) and the reverse process (MET).